Swedish Stirling publishes prospectus supplement
Swedish Stirling AB (publ) ("Swedish Stirling" or the "Company") publishes prospectus supplement for the rights issue.
Today, on 2 January 2023, Swedish Stirling has published a supplement to the rights issue prospectus, which was published on 5 December 2022. The prospectus supplement has been prepared by reason of Swedish Stirling’s announcement on 22 December 2022 that a product sales agreement is unlikely to be reached with Glencore, and that the subscription period in the rights issue was extended until 31 January 2023, and announcement on 30 December 2022 that the Company resolved on extended cost-saving measures and to seek opportunities for strategic partnerships.
Swedish Stirling’s Board of Directors has, in line with what was communicated on 22 December 2022, resolved to waive the subscription and underwriting commitments received by a number of existing shareholders and external investors, meaning that these parties are not bound by their obligations to subscribe for shares in the rights issue. Furthermore, Swedish Stirling has agreed with all external investors who have entered into underwriting commitments that they shall not be entitled to an underwriting fee or have any other claims on the Company in relation to the rights issue.
The supplement, which today has been approved and registered by the Swedish Financial Supervisory Authority, forms part of, and must be read together with, the prospectus. The prospectus and the supplement to the prospectus are available on the Company’s website, www.swedishstirling.com, ABG Sundal Collier AB’s website (www.abgsc.com) and Avanza’s website for prospectuses (www.avanza.se/borsintroduktioner-emissioner.html).
Shareholders and other investors who have already subscribed or applied for subscription for ordinary shares in Swedish Stirling before the supplement to the prospectus was published are entitled to withdraw their subscriptions or applications. The withdrawal period runs from and including 3 January 2023, up to and including 31 January 2023. Any subscription or application that is not withdrawn within the prescribed time will remain binding and those who wish to remain as subscribers do not need to take any further action. Further instructions on how to withdraw an application are to be found in the supplement.
Trading in subscription rights till be resumed on Nasdaq First North Premier Growth Market. Last day for trading in subscription rights will be 26 January 2023. Outcome of the rights issue will be announced once the extended subscription period has ended, estimated on or around 2 February 2023.